5.96
+0.17%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Beijing Leadman Biochemistry Co
Its shares trade on Shenzhen under the ticker 300289.SZ. It has been listed since 16 February 2012. In the fiscal year to 31 December 2025, it reported revenue of CN¥326.3m and a net loss of CN¥23.0m. At that date it held total assets of CN¥1.78bn and shareholders' equity of CN¥1.64bn.
Beijing Leadman Biochemistry Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Beijing, Beijing. The company went IPO on 2012-02-16. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The firm also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The firm mainly operates businesses in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 16 Feb 2012
- Employees
- 519
- Website
- leadmanbio.com ↗
Leadership
Pay as last reported
- Ms. Zi YaoChairman of the Board, since 2024
- Mr. Yaoliang DingActing President, Vice President, since 2016CN¥869,300
- Mr. Xu OuyangFinance DirectorCN¥517,400
- Ms. Lihua ZhangVice President, Secretary of the BoardCN¥1.3m
- Mr. Yanyi HuangDirector
- Mr. Xiangguo LiDirector
- Ms. Na AnIndependent Director
- Mr. Ge YangIndependent Director
- Mr. Zhiqian ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Beijing Leadman Biochemistry Co Ltd employs 519 full-time employees in the Health Care sector.
- The company produces chemiluminescence diagnostic reagents for liver and kidney diseases.
- Beijing Leadman's diagnostic instruments include automatic luminescence immunity analyzers.
Weaknesses
- Beijing Leadman Biochemistry Co Ltd is headquartered in Beijing, China.
- The company's products are primarily applied in domestic market only.
- Beijing Leadman's business focuses on diagnostic reagents and instruments without expansion.
Opportunities
- Beijing Leadman Biochemistry Co Ltd can expand into international markets for diagnostic products.
- The company can leverage its expertise in tumor markers for new product development.
- Beijing Leadman's diagnostic instruments are applicable in cardiovascular disease treatment.
Threats
- Beijing Leadman Biochemistry Co Ltd faces competition from domestic diagnostic firms.
- The company's reliance on domestic market limits growth potential.
- Beijing Leadman's business is vulnerable to regulatory changes in China's Health Care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.